A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease

Non-Invasive Assessment of Liver Disease in Patients with NAFLD

(2019) Laurent Castera et al.   GASTROENTEROLOGY

Nonalcoholic fatty liver disease (NAFLD): Diagnosis, pitfalls, and staging

(2018) Lisa Koch et al.   Annals of Diagnostic Pathology

Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study

(2018) Andreas Geier et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis

(2017) Yukiomi Nakade et al.   HEPATOLOGY RESEARCH

Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Non-alcoholic Fatty Liver Disease: Possible Role for MAPK and NF-κB?

(2016) James E Nelson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

(2016) Ilaria Barchetta et al.   BMC Medicine

Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

(2015) G. Targher et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity

(2014) Lucinda J Black et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Meta-analysis: vitamin D and non-alcoholic fatty liver disease

(2013) M. Eliades et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Systematic Review: Vitamin D and Cardiometabolic Outcomes

(2013) Anastassios G. Pittas   ANNALS OF INTERNAL MEDICINE

NAFLD leads to liver cancer: Do we have sufficient evidence?

(2013) Xiao-Yan Duan et al.   CANCER LETTERS

2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults

(2013) Michael D. Jensen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1(I) collagen expression and type I collagen formation

(2013) James J. Potter et al.   LIVER INTERNATIONAL

Effect of vitamin D3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats

(2012) Naijil George et al.   BRITISH JOURNAL OF NUTRITION

Nonalcoholic Fatty Liver Disease/Steatohepatitis: Epidemiology, Pathogenesis, Clinical Presentation and Treatment

(2012) Sandra Milic et al.   DIGESTIVE DISEASES

Effects of Metformin, Pioglitazone, and Silymarin Treatment on Non- Alcoholic Fatty Liver Disease: A Randomized Controlled Pilot Study

(2012) Ali Akbar Hajiaghamohammadi et al.   Hepatitis Monthly

Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D

(2011) Aruna V. Krishnan et al.   Annual Review of Pharmacology and Toxicology

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis

(2011) Ruben Hernaez et al.   HEPATOLOGY

Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation

(2011) Christian L. Roth et al.   HEPATOLOGY

Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats

(2010) Toshiaki Nakano et al.   JOURNAL OF HEPATOLOGY

GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis

(2009) Jan Piet van Hamburg et al.   ARTHRITIS AND RHEUMATISM

The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective

(2008) Mariana Lazo et al.   SEMINARS IN LIVER DISEASE